Observations on M&A in the 2023 pharma and biopharma marketShifting tides | Market dynamics overviewIn the past few years, a unique confluence of market trends in the life sciences industry has emerged:A decrease in investment due to low-risk appetites alongside sharp inflationary pressures;Division of the life sciences market into the “haves” and “have-nots” due to […]